Insider Buying: Health Catalyst (NASDAQ:HCAT) CEO Acquires $105,610.00 in Stock

Health Catalyst, Inc. (NASDAQ:HCAT) CEO Simeon Kohl acquired 59,000 shares of Health Catalyst stock in a transaction that occurred on Monday, September 14th. The shares were purchased at an average price of $1.79 per share, with a total value of $105,610.00. Following the purchase, the chief executive officer owned 2,856,385 shares in the company, valued at $5,112,929.15. This represents a 2.11% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Health Catalyst Stock Up 0.6%

NASDAQ:HCAT traded up $0.01 during midday trading on Wednesday, reaching $1.73. 337,743 shares of the stock traded hands, compared to its average volume of 1,042,756. The stock has a market capitalization of $130.20 million, a PE ratio of -0.47 and a beta of 1.53. Health Catalyst, Inc. has a 12-month low of $0.96 and a 12-month high of $3.62. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.70 and a current ratio of 2.70. The business has a 50-day moving average of $1.91 and a two-hundred day moving average of $1.64.

Health Catalyst (NASDAQ:HCAT) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.01. The business had revenue of $70.49 million for the quarter, compared to analyst estimates of $69.09 million. Health Catalyst had a negative net margin of 90.61% and a negative return on equity of 1.83%. On average, equities analysts forecast that Health Catalyst, Inc. will post -0.18 earnings per share for the current fiscal year.

Institutional Trading of Health Catalyst

Several institutional investors and hedge funds have recently bought and sold shares of the business. Palogic Value Management L.P. purchased a new stake in shares of Health Catalyst in the 2nd quarter valued at $9,796,000. BlackRock Inc. purchased a new position in shares of Health Catalyst during the second quarter worth $3,654,000. Hsbc Holdings PLC purchased a new position in shares of Health Catalyst during the second quarter worth $809,000. EP Wealth Advisors LLC acquired a new position in Health Catalyst during the second quarter valued at $99,000. Finally, Deutsche Bank AG acquired a new position in Health Catalyst during the second quarter valued at $43,000. 85.00% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on HCAT shares. Wells Fargo & Company dropped their target price on Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating on the stock in a research note on Thursday, August 13th. Weiss Ratings raised Health Catalyst from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, July 28th. Canaccord Genuity Group restated a “hold” rating and set a $1.80 price target (down from $3.00) on shares of Health Catalyst in a research note on Thursday, August 20th. Finally, Citigroup cut their price objective on shares of Health Catalyst from $2.50 to $2.00 and set a “neutral” rating on the stock in a report on Tuesday, August 11th. Three analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $2.45.

About Health Catalyst

Health Catalyst, Inc is a healthcare technology and data analytics company that helps healthcare organizations use data to improve clinical outcomes, operational performance and financial results. The company provides software, data management capabilities and professional services designed to support hospitals, health systems, medical groups and other healthcare providers.

Its offerings include the Health Catalyst Data Operating System, which integrates and organizes data from disparate clinical, financial and operational systems, as well as analytics applications for areas such as quality improvement, population health, cost management and care delivery.